16 September 2026 editorial review · Item
VX-017 blood-type-independent stem-cell islets: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Preventing and curing evidence review — 16 September 2026
- Disposition: corrected/updated. Current item
lastReviewed: 2026-09-16. - Claim check: VX-017 is now Part D of the recruiting master protocol. Updated maturity, display, route, eligibility and citation. Registration does not establish dosing, outcomes, immune-evasion design or a drug-free regimen. Unverified blood-group and C-peptide restrictions were not added.
- Registry NCT04786262: RECRUITING; updated 2026-09-01; enrollment 57 (ESTIMATED); primary completion 2027-12-31 (ESTIMATED); results not posted in retrieved record.
- Programme/sponsor/conference source boundary: Vertex reports second-quarter 2026 financial results (manufacturer).